Creative Planning Invests $258,000 in Surgery Partners, Inc. (NASDAQ:SGRY)

Creative Planning acquired a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) during the 3rd quarter, HoldingsChannel reports. The firm acquired 8,016 shares of the company’s stock, valued at approximately $258,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. ProShare Advisors LLC raised its stake in shares of Surgery Partners by 7.8% in the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after buying an additional 986 shares during the period. First Eagle Investment Management LLC raised its stake in Surgery Partners by 16.5% in the 1st quarter. First Eagle Investment Management LLC now owns 339,474 shares of the company’s stock valued at $10,127,000 after acquiring an additional 48,100 shares during the period. Vanguard Group Inc. lifted its holdings in Surgery Partners by 0.8% during the first quarter. Vanguard Group Inc. now owns 7,479,009 shares of the company’s stock valued at $223,099,000 after purchasing an additional 61,400 shares during the last quarter. EntryPoint Capital LLC boosted its position in Surgery Partners by 257.1% during the first quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock worth $191,000 after purchasing an additional 4,607 shares during the period. Finally, Magnetar Financial LLC increased its stake in shares of Surgery Partners by 511.7% in the first quarter. Magnetar Financial LLC now owns 165,466 shares of the company’s stock worth $4,936,000 after purchasing an additional 138,415 shares in the last quarter.

Surgery Partners Trading Down 0.2 %

Shares of SGRY stock opened at $30.36 on Friday. The company has a quick ratio of 1.69, a current ratio of 1.83 and a debt-to-equity ratio of 0.96. The firm has a market cap of $3.86 billion, a P/E ratio of -112.44, a price-to-earnings-growth ratio of 2.28 and a beta of 2.76. The business has a 50-day moving average price of $31.04 and a two-hundred day moving average price of $28.39. Surgery Partners, Inc. has a 12-month low of $22.25 and a 12-month high of $36.92.

Analysts Set New Price Targets

Several research analysts recently commented on the stock. Benchmark reaffirmed a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a report on Monday, August 26th. Citigroup cut their price target on Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a report on Wednesday, August 7th. Macquarie reissued an “outperform” rating and set a $35.00 price objective on shares of Surgery Partners in a report on Monday, November 4th. UBS Group assumed coverage on Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 target price for the company. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $40.13.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.